WHO Counterfeit Drugs Meeting

18 November 1997

Drug industry officials and government representatives from SouthEastAsia and the western Pacific region discussed measures to combat counterfeit drug supplies at a meeting in the Vietnamese capital, Hanoi, this month, reports Vietnam News.

Participants at the World Health Organization event unanimously agreed to enact legislation designed to combat counterfeit drug sales by the end of 2000, to establish an inter-regional drug administration network and to use the WHO certification Scheme for the registration of drugs. Each country will develop a code of ethics for drug manufacturers and distributors. Reports indicated that recent measures taken by the WHO to combat counterfeit drugs appear to be working.

Vietnam's Ministry of Health says that most counterfeit drugs in Vietnam are antibiotics and analgesics, but that vitamins are also subject to counterfeiting.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight